Ryan S. Napierski
Known title: President and CEOCIK: 0001652984
Associated companies
Transaction History
| NUS | ▲ Buy | Grant | 282,353 | $0 | 3/6/2026 | View on chart |
| NUS | ▼ Sell | Tax Withholding | 124,802 | $1.1M | 2/26/2026 | View on chart |
| NUS | ▼ Sell | Tax Withholding | 49,037 | $410K | 2/15/2026 | View on chart |
| NUS | ▲ Buy | Grant | 42,970 | $0 | 2/10/2026 | View on chart |
| NUS | ▲ Buy | Grant | 206,988 | $0 | 2/10/2026 | View on chart |
| NUS | ▲ Buy | Grant | 310,479 | $0 | 2/26/2025 | View on chart |
| NUS | ▼ Sell | Tax Withholding | 40,857 | $309K | 2/15/2025 | View on chart |
| NUS | ▲ Buy | Grant | 17,694 | $0 | 2/12/2025 | View on chart |
| NUS | ▲ Buy | Grant | 189,574 | $0 | 2/27/2024 | View on chart |
| NUS | ▼ Sell | Tax Withholding | 12,573 | $174K | 2/15/2024 | View on chart |
| NUS | ▲ Buy | Grant | 10,332 | $0 | 2/13/2024 | View on chart |
| NUS | ▲ Buy | Option Exercise | 10,000 | $306K | 2/28/2023 | View on chart |
| NUS | ▼ Sell | Open Market | 9,400 | $380K | 2/28/2023 | View on chart |
| NUS | ▼ Sell | Open Market | 600 | $25K | 2/28/2023 | View on chart |
| NUS | ▲ Buy | Option Exercise | 21,513 | $659K | 2/27/2023 | View on chart |
| NUS | ▼ Sell | Open Market | 21,513 | $890K | 2/27/2023 | View on chart |
| NUS | ▲ Buy | Grant | 53,064 | $0 | 2/22/2023 | View on chart |
| NUS | ▼ Sell | Tax Withholding | 6,963 | $316K | 2/15/2023 | View on chart |
| NUS | ▲ Buy | Option Exercise | 12,000 | $451K | 11/25/2022 | View on chart |
| NUS | ▲ Buy | Option Exercise | 13,000 | $398K | 11/25/2022 | View on chart |
| NUS | ▼ Sell | Open Market | 25,000 | $961K | 11/25/2022 | View on chart |
| NUS | ▲ Buy | Option Exercise | 13,000 | $489K | 8/25/2022 | View on chart |
| NUS | ▲ Buy | Option Exercise | 12,000 | $368K | 8/25/2022 | View on chart |
| NUS | ▼ Sell | Open Market | 12,251 | $524K | 8/25/2022 | View on chart |
| NUS | ▼ Sell | Open Market | 12,749 | $551K | 8/25/2022 | View on chart |
| NUS | ▲ Buy | Option Exercise | 13,000 | $489K | 5/25/2022 | View on chart |
| NUS | ▲ Buy | Option Exercise | 12,000 | $368K | 5/25/2022 | View on chart |
| NUS | ▼ Sell | Open Market | 9,452 | $421K | 5/25/2022 | View on chart |
| NUS | ▼ Sell | Open Market | 15,548 | $702K | 5/25/2022 | View on chart |
| NUS | ▲ Buy | Grant | 31,613 | $0 | 2/25/2022 | View on chart |
| NUS | ▲ Buy | Option Exercise | 18,800 | $707K | 2/25/2022 | View on chart |
| NUS | ▲ Buy | Option Exercise | 6,200 | $190K | 2/25/2022 | View on chart |
| NUS | ▼ Sell | Open Market | 7,253 | $346K | 2/25/2022 | View on chart |
| NUS | ▼ Sell | Open Market | 17,747 | $839K | 2/25/2022 | View on chart |
| NUS | ▼ Sell | Tax Withholding | 4,498 | $223K | 2/15/2022 | View on chart |
| NUS | ▲ Buy | Grant | 13,707 | $0 | 9/1/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 29, 2026
Nu Skin: Turnaround Narrative Gains Attention
A recent analysis suggests that Nu Skin's potential turnaround may be in its early stages. The company currently trades at a low price with a high dividend yield, while the stock is testing a key support level. This context highlights the contrast between current market sentiment and the long-term outlook discussed in the news.
Nu Skin: Turnaround Narrative Gains Attention. A recent analysis suggests that Nu Skin's potential turnaround may be in its early stages. The company currently trades at a low price with a high dividend yield, while the stock is testing a key support level. This context highlights the contrast between current market sentiment and the long-term outlook discussed in the news.